Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sanguine Corp
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sanguine Corp since year 2005.
Table 2 shows the detailed insider transactions of Sanguine Corp since 2005.
The reporting company's ticker symbol is SGNC. The reporting company's CIK number is 926287.
The total value of stock buying since 2005 is $40,000.
The total value of stock sales since 2005 is $37,895.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2008-06-12||Nelson David E (Chief Financial Officer)||Buy||1,000,000||.04||40,000|
|2007-04-05||Kunkel Edward L (Director)||Sale||25,000||.12||3,025|
|2007-04-04||Kunkel Edward L (Director)||Sale||50,000||.12||6,050|
|2005-04-13||Nelson David E (CFO)||Sale||110,000||.26||28,820|
Insider trading activities including stock purchases, stock sales, and option exercises of SGNC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sanguine Corp (symbol SGNC, CIK number 926287) see the Securities and Exchange Commission (SEC) website.